MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 154 filers reported holding MERSANA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,166,161 | +20.4% | 962,359 | +50.4% | 0.02% | +109.1% |
| Q1 2023 | $2,630,400 | +63.2% | 640,000 | +132.7% | 0.01% | -31.2% |
| Q4 2022 | $1,611,500 | -2.7% | 275,000 | +12.2% | 0.02% | +6.7% |
| Q3 2022 | $1,656,000 | -10.4% | 245,000 | -38.8% | 0.02% | +7.1% |
| Q2 2022 | $1,848,000 | +6.5% | 400,000 | -8.0% | 0.01% | -39.1% |
| Q1 2022 | $1,736,000 | -3.8% | 435,000 | +50.0% | 0.02% | +27.8% |
| Q4 2021 | $1,804,000 | +9.3% | 290,000 | +65.7% | 0.02% | -18.2% |
| Q3 2021 | $1,650,000 | +73.5% | 175,000 | +150.0% | 0.02% | +100.0% |
| Q2 2021 | $951,000 | – | 70,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 796,458 | $14,830,000 | 12.35% |
| Consonance Capital Management LP | 3,468,171 | $64,577,000 | 7.87% |
| Sarissa Capital Management LP | 2,837,000 | $52,824,000 | 6.22% |
| Bain Capital Life Sciences Investors, LLC | 3,445,667 | $64,158,000 | 5.98% |
| Ghost Tree Capital, LLC | 1,050,000 | $19,551,000 | 5.65% |
| NEA Management Company, LLC | 5,959,520 | $110,966,000 | 4.70% |
| Soleus Capital Management, L.P. | 393,041 | $7,318,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 667,500 | $12,429,000 | 3.38% |
| Avoro Capital Advisors LLC | 6,800,000 | $126,616,000 | 1.80% |
| FNY Investment Advisers, LLC | 199,800 | $3,720,000 | 1.57% |